World Journal of Hepatology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Luo Y, Wang LJ, Wang CL. Mechanistic interplay between aflatoxin B1 and tissue inhibitor of metalloproteinase-3 in hepatocellular carcinoma. World J Hepatol 2025; 17(10): 109391 [PMID: 41179738 DOI: 10.4254/wjh.v17.i10.109391]
URL:	https://www.wjgnet.com/1948-5182/full/v17/i10/109391.htm

Number	Citing Articles
1	Raza Mohai Ud Din, Xin Zhang, Salwa Eman, Ahmed A. Saleh, Mudathir Y. Abdulrahman, Hosameldeen Mohamed Husien, Shahab ur Rehman, Xiaodong Guo, Ning Chen, Mengzhi Wang. Aflatoxin B1 Toxicity in Animal Models: Biomarker-Guided Mechanisms, Systemic Injury, and Precision Mitigation Strategies. Toxins 2026; 18(8) doi: 10.3390/toxins18080352
2	Fei Li, Qin-Qin Long, Feng-Qin Tian, Mei-Jin Huang, Xi-Dai Long. Molecular characteristics and carcinogenic mechanisms of aflatoxin B1-associated hepatocellular carcinoma: Recent advances. World Journal of Hepatology 2026; 18(9): 123791 doi: 10.4254/wjh.123791 Abstract(35) \| Core Tip(31) \| Full Article(HTML)(94) \| Full Article (PDF)-1105K(22) \| Full Article with Cover (PDF)-1359K(9) \| Full Article (XML)-282K(8) \| Audio-478K(0) \| Peer-Review Report-281K(16) \| Answering Reviewers-273K(13) \| Times Cited (0) \| Total Visits (188) \| Open
3	Fanxin Zeng, Aoran Du, Yu Li, Hong Hu, Lijuan Hu, Rongbin Qiu. TRIP13 Promotes Aflatoxin B1-Induced Hepatocellular Carcinoma Progression by Inhibiting Ferroptosis. Chemical Research in Toxicology 2026; 39(9) doi: 10.1021/acs.chemrestox.6c00310